Wedbush Reiterates Outperform Rating for Generation Bio (NASDAQ:GBIO)
Wedbush reaffirmed their outperform rating on shares of Generation Bio (NASDAQ:GBIO – Free Report) in a research note published on Friday morning,RTT News reports. They currently have a $5.00 price target on the stock. Separately, Needham & Company LLC restated a “buy” rating and set a $8.00 price objective on shares of Generation Bio in […]
